1 Glorious Growth Stock Down 78% to Buy on the Dip in September
This company could spur sales growth by leaning further into artificial intelligence.
In 2020, the COVID-19 pandemic led to widespread lockdowns and social restrictions, prompting businesses to adopt Docusign (NASDAQ: DOCU) for drafting, negotiating, and finalizing commercial agreements remotely. This surge in demand propelled the company's stock to a record high of $310 in late 2021, representing a tenfold increase from its initial public offering (IPO) price of $29 three years prior.
However, as social conditions returned to normal in 2022, demand for Docusign's platform slowed, and its sales growth has been lackluster since. Consequently, the company's stock has declined by 78% from its peak, closing at $68.41 on September 4. Despite this significant drop, Docusign's new Intelligent Agreement Management (IAM) platform, which leverages artificial intelligence (AI) to streamline contract management processes, could be the catalyst for a resurgence.
The AI-driven platform has garnered a positive response from customers, potentially signaling a turning point for the company.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
